Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Aeroplan Members Can Multiply Their Impact for Children Travelling for Essential Medical Care During Points Matching Week
-
CoreCivic Announces 2026 Third Quarter Earnings Release and Conference Call Dates
-
Forward Therapeutics Announces Positive Phase 1 Data for Potential Best-in-Class Oral TNFR1 Signaling Inhibitor FT2109, Supporting Advancement into Phase 2 Development
-
Vortex Energy Commissions Hydrogen and Helium Study at Robinsons River Salt Project
-
Radiopharm Completes Productive End-of-Phase 2 Meeting with U.S. Food and Drug Administration for Pivotal Development Program of RAD101
-
Northern Discovery Metals Completes Fieldwork at the Vent Copper Project
-
Sofwave to Participate in the Jefferies Private MedTech Virtual Summit
-
PMV Pharmaceuticals Appoints Matt Eckler, Ph.D., to Board of Directors
-
Airsys and Shell Showcase Spray Liquid Cooling for Data Centers at OCP Global Summit
-
Celcuity Announces Multiple Presentations At The European Society For Medical Oncology (ESMO) Congress 2026
-
SeaStar Medical Announces Exercise of Warrants for Approximately $3.3 Million Gross Proceeds
-
Syntec Optics (Nasdaq: OPTX) Lands Artemis III Production Orders, Expands Space Portfolio to Moon Missions
-
MindWave Innovations Signs Agreement with US-Based BlockAssure to Build and Operate AssureChain, an End-to-End Insurance and Reinsurance Network
-
Mastercard Selects Rezolve Ai in Worldwide Reseller Agreement to Advance AI-Powered Commerce
-
Coveron completes SOC 2 Type II certification with zero exceptions
-
Osisko Gold Intersects 7.28 g/t Au over 16.15 m (105 m Vertical Depth), including 173.66 g/t Au over 0.60 m, and 7.13 g/t Au over 11.60 m (61 m Vertical Depth) in Lowhee Zone Underground Infill Drilli
-
Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces First Patient Dosed in Phase 2 Clinical Trial of MAR002, a Potential Best-in-disease Investigational Therapy for the Treatment of Acr
-
Pacira Announces Exclusive Agreement with Molteni Farmaceutici to Commercialize EXPAREL® in the European Union and United Kingdom
-
DFDV Preliminary Q3’26 Estimates Indicate Double-Digit SPS Growth and More Than 100% NAV Per Share Growth In Q3; SOL Treasury Growth Rises to 11% Since August 12
-
VoltaGrid Completes $775 Million Primary Equity Investment and Upsized $800 Million Secondary Equity Investment
-
vTv Therapeutics Announces Completion of Enrollment in Phase 3 CATT1 Study of Cadisegliatin in Type 1 Diabetes (T1D)
-
Prime Medicine Announces First Patient Dosed in Global Phase 1/2 Clinical Trial of PM577a for H1069Q-Mutated Wilson Disease
-
TELA Bio Announces 510(k) Clearance for Liora™ Monofilament Scaffold for Soft Tissue Reinforcement
-
Kratos Secures More Than $100 Million in Contracts for Space and Cyber Mission Capabilities
-
Magnite to Announce Third Quarter 2026 Financial Results on November 4, 2026
-
OnCusp Therapeutics Announces Positive Phase 1b Data Evaluating its CDH6-Directed Antibody-Drug Conjugate, CUSP06, in Platinum-Resistant Ovarian Cancer (PROC) Presented at Plenary Oral Session of the
-
Cerevance Appoints Karl Kieburtz, M.D., M.P.H., as Chief Medical Officer
-
MAPS and International Alliance of Psychedelic Therapy Practitioners Announce Partnership to Advance Training for Psychedelic-Assisted Therapy
-
Baird Medical Highlights Global Expansion and Strategic Progress During Third Quarter 2026
-
Trasteel Holding S.A., Through Newly Established Trasteel Magona, Takes Over Operations of La Magona d’Italia Steel Plant in Piombino, Italy
-
4DMT to Host Investor Day on October 21, 2026
-
Altus Achieves Leading AI Governance Certification, Setting New Standard for Responsible AI in Commercial Real Estate
-
Gate Bioscience Expands Collaboration and License Agreement with Lilly to Target Difficult-to-Drug Proteins
-
PDAOAI Opens BIO REBOOT Collaboration and Showcases Partitioned Literature Aggregation at Drug Discovery 2026
-
Safety in Action® Conference Celebrates 40 Years of Advancing Workplace Safety in 2027
-
Angeion Group Names Lenny Izzo as Managing Director, Corporate Bankruptcy
-
BEYYON Rechargeable Hand Warmers with LED Displays: Two Market-Tested Cold-Weather Essentials, Each in a 2-Pack
-
Inside Information: Preliminary result of Martela Corporation’s directed share issue
-
Orion Pharma announces first patient dosed in Phase 1/2 clinical trial of ODM-216, the company’s first biologic candidate to reach clinical testing
-
ASML reports transactions under its current share buyback program
-
STMicroelectronics announces status of common share repurchase program
-
Kvika banki hf.: Transaction in relation to a share buy-back programme
-
Arcadia Launches Healthcare Performance Platform to Improve Clinical, Operational, and Financial Outcomes
-
PÜR Minerals Continues Its Award-Winning Legacy with 4-in-1 Skin Tint Mineral SPF 50, Reinforcing Its Position as The Complexion Authority
-
AGM Group Holdings Inc. Announces Closing of US$11.0 million Private Placement
-
Repayments, Realkredit Danmark A/S
-
AID FOR AIDS and AID FOR LIFE to Celebrate 30 Years of Global Humanitarian Impact at My Hero Gala in New York
-
Zenflow Secures $52M Series D Financing and Announces Exclusive U.S. Distribution Partnership with Cook Medical
-
Duck My Duck Surpasses 6 Million Players as NFT Trading Volume on Getgems Reaches 55,000 GRAM
-
Polyrizon Files for U.S. Patent Application to Expand IP Moat Around Intranasal Drug-Delivery Platform
